WEBINAR: Clinical Potential of FES PET Imaging for Patients with Metastatic Lobular Breast Cancer
December 2 @ 12:00 PM - 1:00 PM EST
The Lobular Breast Cancer Alliance will present the educational webinar Clinical Potential of 18F-fluoroestradiol (FES) PET Imaging for Patients with Metastatic Lobular Breast Cancer on December 2, 2021. The pre-recorded webinar, moderated by LBCA Executive Director Laurie Hutcheson, will feature radiologist and LBCA Scientific Advisory Board Member Dr. Gary Ulaner, oncologist Dr. Hannah Linden, and a patient with metastatic ILC who all have experience with Fluoroestradiol (FES) used with Positron Emission Tomography (PET). FES/PET is a new imaging resource being used in metastatic ILC imaging.
The intent of the educational webinar is to share information about its use with metastatic ILC to assess hormone treatment efficacy, and to discuss other potential applications the drug may hold for imaging in treating patients with ILC. This webinar is made possible with a sponsorship from GE Healthcare.
The event will premiere on LBCA’s Facebook page.